Snakebite asv protocol
snakebite antivenom ASV protocol indications dosing administration
snakebite management clinical features envenomation treatment
| Syndrome | Common Snakes | Features |
|---|---|---|
| Cytotoxic/Local | Vipers (Russell's, Saw-scaled) | Swelling, necrosis, pain, blistering |
| Haemotoxic | Russell's viper, Saw-scaled viper | Bleeding gums, hematuria, 20WBCT positive, coagulopathy |
| Neurotoxic | Krait, Cobra | Ptosis, ophthalmoplegia, bulbar palsy, respiratory failure |
| Myotoxic | Sea snakes | Myalgia, myoglobinuria, rhabdomyolysis |
Note: A dry bite (no envenomation) does NOT require ASV. Local swelling alone (without progression) is a relative indication.
| Presentation | Initial Dose |
|---|---|
| Neurotoxic envenomation | 10 vials IV |
| Haemotoxic envenomation | 10 vials IV |
| Mixed/severe | 10–20 vials IV |
There is no maximum total dose — give as many vials as needed to achieve clinical neutralization.
| Drug | Dose | Route |
|---|---|---|
| Adrenaline (epinephrine) 1:1000 | 0.25 mg (adult) / 0.01 mg/kg (child) | SC, 15 min before ASV |
| Promethazine | 25 mg adult / 0.5 mg/kg child | IV/IM |
| Hydrocortisone | 100–200 mg | IV |
WHO 2010 does not routinely recommend prophylaxis due to lack of evidence; have adrenaline drawn up and ready at all times.
| Time | Action |
|---|---|
| 0 min | Baseline vitals, 20WBCT, CBC, BUN/Cr, LFT, urine |
| 30 min | Monitor for anaphylaxis during infusion |
| 1–2 hr | Reassess clinical response |
| 6 hr | Repeat 20WBCT; repeat ASV if still positive |
| 12 hr | Repeat labs |
| 24 hr | Reassess, repeat 20WBCT |
| Daily | Continue until 20WBCT normal ×2, neurotoxic signs resolving |
Pressure immobilization bandage is appropriate ONLY for neurotoxic bites (krait, cobra, sea snake) where local effects are minimal.